Zura Bio (NASDAQ:ZURA) & Creative Medical Technology (NASDAQ:CELZ) Head-To-Head Contrast

Creative Medical Technology (NASDAQ:CELZ) and Zura Bio (NASDAQ:ZURA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Profitability

This table compares Creative Medical Technology and Zura Bio’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Creative Medical Technology	N/A	-41.48%	-40.22%
Zura Bio	N/A	-82.30%	-66.71%

Analyst Ratings

This is a summary of recent ratings for Creative Medical Technology and Zura Bio, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Creative Medical Technology	0	0	0	0	N/A
Zura Bio	0	0	4	1	3.20

Zura Bio has a consensus price target of $16.40, indicating a potential upside of 420.63%. Given Zura Bio’s higher possible upside, analysts plainly believe Zura Bio is more favorable than Creative Medical Technology.

Volatility & Risk

Creative Medical Technology has a beta of 2.2, suggesting that its stock price is 120% more volatile than the S&P 500. Comparatively, Zura Bio has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500.

Institutional & Insider Ownership

1.4% of Creative Medical Technology shares are owned by institutional investors. Comparatively, 61.1% of Zura Bio shares are owned by institutional investors. 3.3% of Creative Medical Technology shares are owned by insiders. Comparatively, 15.8% of Zura Bio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Creative Medical Technology and Zura Bio’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Creative Medical Technology	$10,000.00	718.08	-$5.29 million	($3.71)	-1.42
Zura Bio	N/A	N/A	-$69.24 million	N/A	N/A

Creative Medical Technology has higher revenue and earnings than Zura Bio.

About Creative Medical Technology

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

About Zura Bio

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.